Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Pharmacy and Pharmaceutical Sciences (36)
- Medical Specialties (18)
- Diseases (17)
- Medical Sciences (16)
- Other Chemicals and Drugs (14)
-
- Life Sciences (12)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (11)
- Medical Education (11)
- Public Health (11)
- Health Information Technology (10)
- Other Pharmacy and Pharmaceutical Sciences (10)
- Pediatrics (10)
- Pharmaceutics and Drug Design (10)
- Dietetics and Clinical Nutrition (8)
- Health Services Administration (8)
- Health and Medical Administration (8)
- Pharmacy Administration, Policy and Regulation (8)
- Therapeutics (8)
- Medical Pharmacology (6)
- Amino Acids, Peptides, and Proteins (5)
- Medical Neurobiology (5)
- Nanomedicine (5)
- Nanotechnology (5)
- Nervous System Diseases (5)
- Animal Experimentation and Research (4)
- Cancer Biology (4)
- Cell and Developmental Biology (4)
- Institution
-
- Children's Mercy Kansas City (11)
- Southwestern Oklahoma State University (10)
- Chapman University (8)
- University of Nebraska - Lincoln (8)
- Rowan University (5)
-
- University of Nebraska Medical Center (4)
- James Madison University (2)
- University of Connecticut (2)
- University of Kentucky (2)
- University of North Dakota (2)
- Western Kentucky University (2)
- City University of New York (CUNY) (1)
- Claremont Colleges (1)
- Colby College (1)
- Georgia Southern University (1)
- Old Dominion University (1)
- Otterbein University (1)
- Southern Methodist University (1)
- Stephen F. Austin State University (1)
- University of Nebraska at Omaha (1)
- University of New Mexico (1)
- University of South Carolina (1)
- University of Texas at Tyler (1)
- Wayne State University (1)
- Western University (1)
- Keyword
-
- Pharmacy (10)
- Rural (10)
- Rural Rocks (10)
- Adolescent (3)
- Child (3)
-
- Alzheimer’s disease (2)
- CRISPR (2)
- Erythropoietin (2)
- Lipid nanoparticles (2)
- Microfluidics (2)
- Nanoparticles (2)
- Opiods (2)
- Pharmaceutical Preparations (2)
- Pharmacology (2)
- Population pharmacokinetics (2)
- RNA therapeutics (2)
- SiRNA (2)
- Smoking (2)
- Transferrin receptor (2)
- 1 (1)
- 3 (1)
- 4-oxadiazole (1)
- ART (1)
- Acridone (1)
- Addiction (1)
- Adsorption of excipients (1)
- Aerosol (1)
- Aging (1)
- Alcohol (1)
- Amiodarone (1)
- Publication
-
- RURAL ROCKS (10)
- United States Food and Drug Administration: Publications (8)
- Pharmacy Faculty Articles and Research (7)
- Posters (7)
- Rowan-Virtua Research Day (5)
-
- Theses & Dissertations (4)
- Manuscripts, Articles, Book Chapters and Other Papers (3)
- Masters Theses & Specialist Projects (2)
- Physician Assistant Capstones, 2016 to 2019 (2)
- Physician Assistant Scholarly Project Posters (2)
- Biological Sciences Theses and Dissertations (1)
- Biomedical Engineering ETDs (1)
- Clinical Research in Practice: The Journal of Team Hippocrates (1)
- Dissertations, Theses, and Capstone Projects (1)
- Faculty Posters (1)
- Faculty Publications (1)
- Honors Scholar Theses (1)
- Honors Theses (1)
- Library Articles and Research (1)
- National Youth Advocacy & Resilience Conference (1)
- OUR Journal: ODU Undergraduate Research Journal (1)
- Presentations (1)
- Scripps Senior Theses (1)
- Senior Theses (1)
- Theses and Dissertations--Chemistry (1)
- Theses and Dissertations--Pharmacy (1)
- UNO Student Research and Creative Activity Fair (1)
- Undergraduate Honors Thesis Projects (1)
- University Scholar Projects (1)
- Western Research Forum (1)
- Publication Type
- File Type
Articles 61 - 70 of 70
Full-Text Articles in Pharmaceutical Preparations
Development Of A Chemical Genetic Screen To Identify Compounds That Enhance Laromustine Cytotoxicity, Xiaoou Wang
Development Of A Chemical Genetic Screen To Identify Compounds That Enhance Laromustine Cytotoxicity, Xiaoou Wang
Honors Theses
Laromustine is a chemotherapeutic sulfonylhydrazine prodrug used in clinical trials against acute myeloid leukemia. Though laromustine showed some success in clinical trials, more experiments are needed to understand the hematological toxicity and the molecular mechanisms of patients’ resistance. This project aims to develop a strategy to identify compounds synergistic with laromustine in cultured leukemia cells from a library of 450 FDA-approved compounds through a forward chemical genetic screen. To optimize the screen, the cell seeding density, doubling time, and dose response curves were determined. The optimized concentration of HL60 cells in these experiments was determined to be between 25,000 and …
The Impact Of Medical Marijuana On The Opioid Crisis, Carl David Eastep
The Impact Of Medical Marijuana On The Opioid Crisis, Carl David Eastep
Physician Assistant Scholarly Project Posters
• The opioid crisis dictates the need for research into alternative treatments for acute and chronic pain.
• Comprehensive literature review was conducted to determine if medical marijuana might play a role in the treatment of acute and chronic pain.
• The addiction profiles of medical marijuana and prescription opiates were compared along with the adverse effects and quality of life.
• No use for medical marijuana for the treatment of acute pain.
• Likely some benefits from medical marijuana for chronic pain.
• Addictive profile
• Marijuana – marijuana withdrawal syndrome.
• Prescription Opiates – highly addictive
• Adverse …
At Risk Alcohol Consumption With Smoking By National Background: Results From The Hispanic Community Health Study/Study Of Latinos, Frank C. Bandiera, Eliseo J. Pérez-Stable, Folefac Atem, Raul Caetano, Denise C. Vidot, Marc D. Gellman, Elena L. Navas-Nacher, Jianwen Cai, Gregory Talavera, Neil Schneiderman, Robert Kaplan
At Risk Alcohol Consumption With Smoking By National Background: Results From The Hispanic Community Health Study/Study Of Latinos, Frank C. Bandiera, Eliseo J. Pérez-Stable, Folefac Atem, Raul Caetano, Denise C. Vidot, Marc D. Gellman, Elena L. Navas-Nacher, Jianwen Cai, Gregory Talavera, Neil Schneiderman, Robert Kaplan
United States Food and Drug Administration: Publications
Introduction: Tobacco smoking and binge or excess drinking are unhealthy behaviors that frequently co-occur. Studies of Hispanics/Latinos have mostly been of Mexican Americans although there are substantial differences in smoking and drinking by heritage background. Associated with co-use by 5 subpopulations.
Methods: Cross-sectional data of 16,412 Hispanics/Latinos from Miami, the Bronx, Chicago and San Diego collected between 2008 and 2011 as part of the HCHS/SOL were analyzed. Smoking and alcohol consumption and demographic data were measured by self-report. Prevalence of smoking and alcohol consumption and co-use were reported. Logistic regression models examined the odds of co-use of smoking and binge …
Comparing Methods For Clinical Investigator Site Inspection Selection: A Comparison Of Site Selection Methods Of Investigators In Clinical Trials, Nicholas Hein, Elena Rantou, Paul Schuette
Comparing Methods For Clinical Investigator Site Inspection Selection: A Comparison Of Site Selection Methods Of Investigators In Clinical Trials, Nicholas Hein, Elena Rantou, Paul Schuette
United States Food and Drug Administration: Publications
Background During the past two decades, the number and complexity of clinical trials have risen dramatically increasing the difficulty of choosing sites for inspection. FDA’s resources are limited and so sites should be chosen with care.
Purpose To determine if data mining techniques and/or unsupervised statistical monitoring can assist with the process of identifying potential clinical sites for inspection.
Methods Five summary-level clinical site datasets from four new drug applications (NDA) and one biologics license application (BLA), where the FDA had performed or had planned site inspections, were used. The num- ber of sites inspected and the results of the …
Mechanisms And Thermodynamics Of The Influence Of Solution-State Interactions Between Hpmc And Surfactants On Mixed Adsorption Onto Model Nanoparticles, Salin Gupta Patel
Mechanisms And Thermodynamics Of The Influence Of Solution-State Interactions Between Hpmc And Surfactants On Mixed Adsorption Onto Model Nanoparticles, Salin Gupta Patel
Theses and Dissertations--Pharmacy
Nanoparticulate drug delivery systems (NDDS) such as nanocrystals, nanosuspensions, solid-lipid nanoparticles often formulated for the bioavailability enhancement of poorly soluble drug candidates are stabilized by a mixture of excipients including surfactants and polymers. Most literature studies have focused on the interaction of excipients with the NDDS surfaces while ignoring the interaction of excipients in solution and the extent to which the solution-state interactions influence the affinity and capacity of adsorption. Mechanisms by which excipients stabilize NDDS and how this information can be utilized by formulators a priori to make a rational selection of excipients is not known.
The goals of …
Hematologic Safety Of Chronic Brain-Penetrating Erythropoietin Dosing In App/Ps1 Mice, Jiahong Sun, Joshua Yang, Kathrine Whitman, Charlene Zhu, David H. Cribbs, Ruben J. Boado, William M. Pardridge, Rachita K. Sumbria
Hematologic Safety Of Chronic Brain-Penetrating Erythropoietin Dosing In App/Ps1 Mice, Jiahong Sun, Joshua Yang, Kathrine Whitman, Charlene Zhu, David H. Cribbs, Ruben J. Boado, William M. Pardridge, Rachita K. Sumbria
Pharmacy Faculty Articles and Research
Introduction: Low blood-brain barrier (BBB) penetration and hematopoietic side effects limit the therapeutic development of erythropoietin (EPO) for Alzheimer's disease (AD). A fusion protein of EPO and a chimeric monoclonal antibody targeting the mouse transferrin receptor (cTfRMAb) has been engineered. The latter drives EPO into the brain via receptor-mediated transcytosis across the BBB and increases its peripheral clearance to reduce hematopoietic side effects of EPO. Our previous work shows the protective effects of this BBB-penetrating EPO in AD mice but hematologic effects have not been studied. Herein, we investigate the hematologic safety and therapeutic effects of chronic cTfRMAb-EPO dosing, …
An Open-Label, Single-Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Cinacalcet In Pediatric Subjects Aged 28 Days To < 6 Years With Chronic Kidney Disease Receiving Dialysis., Winnie Y. Sohn, Anthony A. Portale, Isidro B. Salusky, Hao Zhang, Lucy L. Yan, Bella Ertik, Shahnaz Shahinfar, Edward Lee, Bastian Dehmel, Bradley A. Warady
An Open-Label, Single-Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Cinacalcet In Pediatric Subjects Aged 28 Days To < 6 Years With Chronic Kidney Disease Receiving Dialysis., Winnie Y. Sohn, Anthony A. Portale, Isidro B. Salusky, Hao Zhang, Lucy L. Yan, Bella Ertik, Shahnaz Shahinfar, Edward Lee, Bastian Dehmel, Bradley A. Warady
Manuscripts, Articles, Book Chapters and Other Papers
BACKGROUND: Calcimimetics, shown to control biochemical parameters of secondary hyperparathyroidism (SHPT), have well-established safety and pharmacokinetic profiles in adult end-stage renal disease subjects treated with dialysis; however, such studies are limited in pediatric subjects.
METHODS: In this study, the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of cinacalcet were evaluated in children with chronic kidney disease (CKD) and SHPT receiving dialysis. Twelve subjects received a single dose of cinacalcet (0.25 mg/kg) orally or by nasogastric or gastric tube. Subjects were randomized to one of two parathyroid hormone (PTH) and serum calcium sampling sequences: [(1) 2, 8, 48 h; or (2) …
Breaking The Paradigm: Dr Insight Empowers Signature-Free, Enhanced Drug Repurposing, Jinyan Chan, Xuan Wang, Jacob A. Turner, Nicole E. Baldwin, Jinghua Gu
Breaking The Paradigm: Dr Insight Empowers Signature-Free, Enhanced Drug Repurposing, Jinyan Chan, Xuan Wang, Jacob A. Turner, Nicole E. Baldwin, Jinghua Gu
Faculty Publications
Motivation: Transcriptome-based computational drug repurposing has attracted considerable interest by bringing about faster and more cost-effective drug discovery. Nevertheless, key limitations of the current drug connectivity-mapping paradigm have been long overlooked, including the lack of effective means to determine optimal query gene signatures. Results: The novel approach Dr Insight implements a frame-breaking statistical model for the ‘hand-shake’ between disease and drug data. The genome-wide screening of concordantly expressed genes (CEGs) eliminates the need for subjective selection of query signatures, added to eliciting better proxy for potential disease-specific drug targets. Extensive comparisons on simulated and real cancer datasets have validated the …
Discovery Of Selective Probes Targeting Rna Polymerase I, Xiao Tan
Discovery Of Selective Probes Targeting Rna Polymerase I, Xiao Tan
Theses and Dissertations--Chemistry
RNR Polymerase I (RNA Pol I) is a “factory” that orchestrate the transcription of ribosomal rRNA for constructing ribosomes as a primary workshop for protein translation to sustain cell growth. Misregulation of RNA Pol I can cause uncontrolled cell proliferation, which leads to the development of cancer. Yeast (Saccharomyces cerevisiae) is a valuable model system to study RNA Pol I. Recently, the X-ray crystal structure of the yeast homologue of RNA Pol I was elucidated, offering the structural basis to selectively target this transcriptional machinery. The approach to selective RNA Pol I targeting was to disrupt the interaction …
Identification Of Antibiotic Ge37468a From Pseudonocardia Symbionts Of Trachymyrmex Septentrionalis Ants, Krithika Rao
Identification Of Antibiotic Ge37468a From Pseudonocardia Symbionts Of Trachymyrmex Septentrionalis Ants, Krithika Rao
Scripps Senior Theses
In response to the growing rates of antibiotic resistance in human bacterial pathogens, this study explores the natural products involved in the defensive symbiosis between actinobacteria and fungus-growing ants to uncover new potential antibiotics. This study also seeks to understand the function of natural antibiotics in their ecological contexts, especially those involved in defensive symbioses. Defensive symbiosis can be a beneficial platform for discovering useful antibiotics, because antibiotics in these relationships must be able to selectively inhibit enemies without harming hosts, and are therefore likely more specific and less toxic. Pseudonocardia sp. associated with Trachymyrmex septentrionalis ants demonstrated antibiotic activity …